VITROS Chemistry Products LAC Slides on VITROS XT 3400 and VITROS XT 7600 Systems are experiencing an increased occurrence of calibration failure related to lots from coating 0130 and above…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
VITROS Chemistry Products LAC Slides on VITROS XT 3400 and VITROS XT 7600 Systems are experiencing an increased occurrence of calibration failure related to lots from coating 0130 and above…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
Generations 67 and above of VITROS Ca Slides are experiencing an increased occurrence of Condition Code TH4-63J during calibration on VITROS XT 3400 and VITROS XT 7600 Systems, causing…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
Quality control (QC) drift when certain lots of Performance Verifiers (PVs) are used with certain lots of cholinesterase enzyme (CHE) slides. This drift occurs when the PVs are used 2-7…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
Quality control (QC) drift when certain lots of Performance Verifiers (PVs) are used with certain lots of cholinesterase enzyme (CHE) slides. This drift occurs when the PVs are used 2-7…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
Quality control (QC) drift when certain lots of Performance Verifiers (PVs) are used with certain lots of cholinesterase enzyme (CHE) slides. This drift occurs when the PVs are used 2-7…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
Quality control (QC) drift when certain lots of Performance Verifiers (PVs) are used with certain lots of cholinesterase enzyme (CHE) slides. This drift occurs when the PVs are used 2-7…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
Lots from Generation (GEN) 15 of VITROS Chemistry Products OP Reagent may generate lower than expected quality control (QC) results. If the customer is unable to get passing quality control…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
a software anomaly allows test results to be reported using Micro Tip and Micro Slide diluent packs that the system treats as expired even when the Use Expired Reagents setting is not…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
a software anomaly allows test results to be reported using Micro Tip and Micro Slide diluent packs that the system treats as expired even when the Use Expired Reagents setting is not…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
A software anomaly allows test results to be reported using Micro Tip and Micro Slide diluent packs that the system treats as expired even when the Use Expired Reagents setting is not…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
It was determined that there could be a false positive rate of up to 16.7% for the affected lots associated with the Bordetella parapertussis (BPP) results (only) of the assay.
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
The VITROS XT 7600 Integrated System software versions 3.8.0 may not correctly notify users if the Signal Reagent Pack exceeds the on-board and/or shelf-life expiration date. This could…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
The VITROS 5600 Integrated System software versions 3.8.0 may not correctly notify users if the Signal Reagent Pack exceeds the on-board and/or shelf-life expiration date. This could result…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
The VITROS 3600 Immunodiagnostic System software versions 3.8.0 may not correctly notify users if the Signal Reagent Pack exceeds the on-board and/or shelf-life expiration date. This could…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
May Generate Negatively Biased Results When Testing Samples with High Concentrations of CRP, showing less than upper AMI of 90 mg/L (in the 70-90 mg/L range) while the samples having higher…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
The reason for this recall is QuidelOrtho has determined that during normal use the VITROS XT ALB-TP Slides may shed dust and debris as they travel through the MicroSlide Subsystem of the…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
It was confirmed that fibrinogen in patient plasma samples precipitates out of solution upon the addition of folate stabilizer reagent as part of the pre-treatment process causing the…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
Kit assigned an extended expiration date of 24-Jul-2025 during release. The correct expiration date for Lot 2953 is 24-Jul-2024. If used past its true expiration and the customer does not…
Class IIIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
VITROS Chemistry Products FS Diluent Pack 3, Lot 01-1645 may cause results to be negatively biased when used to dilute patient samples tested with VITROS Chemistry Products CRP Slides.
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
The results generated by the VITROS Immunodiagnostic Products Vitamin B12 Range Verifier Lot# 1200 RV Level 2 may cause range verification failure. The issue is detectable by the user when…
Class IIIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
A software defect affecting VITROS Systems running VITROS Software Versions 3.8.1 causes QC baseline statistics to not update as expected when changed by the user. This may cause erroneous…
Class IIFDA: OngoingOrtho-Clinical Diagnostics, Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Ortho-Clinical Diagnostics, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.